000 01592 a2200493 4500
005 20250518003042.0
264 0 _c20191107
008 201911s 0 0 eng d
022 _a1460-2180
024 7 _a10.1093/carcin/bgy130
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLiu, Pengyu
245 0 0 _aAction and clinical significance of CCAAT/enhancer-binding protein delta in hepatocellular carcinoma.
_h[electronic resource]
260 _bCarcinogenesis
_c03 2019
300 _a155-163 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aCCAAT-Enhancer-Binding Protein-delta
_xgenetics
650 0 4 _aCarcinoma, Hepatocellular
_ximmunology
650 0 4 _aCell Proliferation
650 0 4 _aHep G2 Cells
650 0 4 _aHumans
650 0 4 _aLiver Neoplasms
_ximmunology
650 0 4 _aMice
650 0 4 _aRNA, Messenger
_xanalysis
650 0 4 _aSequence Analysis, RNA
700 1 _aCao, Wanlu
700 1 _aMa, Buyun
700 1 _aLi, Meng
700 1 _aChen, Kan
700 1 _aSideras, Kostandinos
700 1 _aDuitman, Jan-Willem
700 1 _aSprengers, Dave
700 1 _aKhe Tran, T C
700 1 _aIjzermans, Jan N M
700 1 _aBiermann, Katharina
700 1 _aVerheij, Joanne
700 1 _aSpek, C Arnold
700 1 _aKwekkeboom, Jaap
700 1 _aPan, Qiuwei
700 1 _aPeppelenbosch, Maikel P
773 0 _tCarcinogenesis
_gvol. 40
_gno. 1
_gp. 155-163
856 4 0 _uhttps://doi.org/10.1093/carcin/bgy130
_zAvailable from publisher's website
999 _c28943323
_d28943323